\u8b1b\u7fa9\u540d\u79f0\uff1a\u30b2\u30ce\u30e0\u533b\u5b66 II \uff08Genomic Medicine II\uff09
\u958b\u8b1b\u5e74\u5ea6\u30fb\u958b\u8b1b\u671f\uff1a\u30002023\u5e74\u5f8c\u671f
\u65e5\u6642\uff1a\u3000 PandA \u30aa\u30f3\u30c7\u30de\u30f3\u30c9
\u5834\u6240\uff1a\u3000\u30aa\u30f3\u30e9\u30a4\u30f3\uff08PandA\uff09
\u5358\u4f4d\u6570\uff1a\u30004<\/p>\n\n\n\n
(\u6388\u696d\u306e\u6982\u8981\u30fb\u76ee\u7684)DNA sequencing technology is increasingy popularized, the application of this technology in the clinical medicine is now coming into reality. The aim of this course is to provide knowledges which are necessary to understand Genomic Medicine. In this Genomic Medicine II, which is the latter half of the Genomic Medicine course through the year, the link between basic science and clinical medicine will be focused, from the currently ongoing practice to future perspectives. A lecture is provided by expert researcher each week.<\/p>\n\n\n\n
(\u5230\u9054\u76ee\u6a19)
– Understand the basic concepts behind Genomic Medicine
– Learn about current and upcoming application of genetic information in the clinical practice
– Learn about future perspectives of this field<\/p>\n\n\n\n
(\u6388\u696d\u8a08\u753b\u3068\u5185\u5bb9)<\/p>\n\n\n\n
\u201cEnhancer & Disease\u201d Prof. Murakawa Yasuhiro \u3010Media class, on-demand type\u3011<\/p>\n\n\n\n
\u201cGenome, Disease and Artificial Intelligence\u201d Assoc. Kawaguchi Shuji \u3010Media class, on-demand type\u3011<\/p>\n\n\n\n
\u201cHigh-Dimensional Statistical Methods: Challenges and Innovations\u201d
(Institute of Epidemiology and Preventive Medicine, National Taiwan University) \u3010Media class, on-demand type\u3011<\/p>\n\n\n\n
\u201cGenetics of diseases: Structural Variants & Quantitative traits\u201d Prof. Masao Nagasaki \u3010Media class, on-demand type\u3011<\/p>\n\n\n\n
\u201cCOVID-19\u201d Prof. Masao Nagasaki \u3010Media class, on-demand type\u3011<\/p>\n\n\n\n
\u201cGenomic Database Resources for Rare Diseases\u201d Prof. Masao Nagasaki \u3010Media class, on-demand type\u3011<\/p>\n\n\n\n
\u201cGenomics for Drug Discovery\u201d Prof. Yukinori Okada \u3010Media class, on-demand type\u3011<\/p>\n\n\n\n
\u201cPharmacogenomics\u201d Prof. Taisei Mushiroda,Team leader, RIKEN Center for Integrative Medical Sciences \u3010Media class, on-demand type\u3011<\/p>\n\n\n\n
\u201cPattern Discovery\u201d Dr. Mario Foglio \u3010Media class, on-demand type\u3011<\/p>\n\n\n\n
\u201cDestructive innovation of vaccine R&D during and after COVID-19\u201d Prof. Ken Ishii,The University of Tokyo \u3010Media class, on-demand type\u3011<\/p>\n\n\n\n
\u201cAnalysis for highly polymorphic regions\u201d Assoc. Kawaguchi Shuji \u3010Media class, on-demand type\u3011<\/p>\n\n\n\n
\u201cA condensed overview of methods in Infectious Disease Public Health\u201d Dr. PAUL, Richard, Institut Pasteur, Unit of Functional Genetics of Infectious Diseases \u3010Media class, on-demand type\u3011<\/p>\n\n\n\n
(\u5c65\u4fee\u8981\u4ef6)Student needs to have will to make use of genomics and other omics information into clinical medicine in the future.<\/p>\n\n\n\n
(\u6210\u7e3e\u8a55\u4fa1\u306e\u65b9\u6cd5\u30fb\u89b3\u70b9)Evaluated by submission assignments.<\/p>\n\n\n\n
(\u6559\u79d1\u66f8)\u6388\u696d\u4e2d\u306b\u6307\u793a\u3059\u308b Informed in class.<\/p>\n\n\n\n
(\u6388\u696d\u5916\u5b66\u4fee\uff08\u4e88\u7fd2\u30fb\u5fa9\u7fd2\uff09\u7b49)NA<\/p>\n\n\n\n
(\u305d\u306e\u4ed6\uff08\u30aa\u30d5\u30a3\u30b9\u30a2\u30ef\u30fc\u7b49\uff09) This class will be offered online.
\u30aa\u30d5\u30a3\u30b9\u30a2\u30ef\u30fc\u306e\u8a73\u7d30\u306b\u3064\u3044\u3066\u306f\u3001KULASIS\u3067\u78ba\u8a8d\u3057\u3066\u304f\u3060\u3055\u3044\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
\u8b1b\u7fa9\u540d\u79f0\uff1a\u30b2\u30ce\u30e0\u533b\u5b66 II \uff08Genomic Medicine II\uff09\u958b\u8b1b\u5e74\u5ea6\u30fb … \u7d9a\u304d\u3092\u8aad\u3080